Small-cell carcinomas of the lung, prostatic adenocarcinomas, papillary thyroid carcinomas, malignant melanomas, giant cell tumors, and osteosarcomas were negative for CEACAM6. This evidence concerns the gene CEACAM6 and thyroid gland papillary carcinoma.